Special Report - The Autism Spectrum Disorders Market: Substantial Opportunity and Unique Challenges

Table of Contents

• Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
• Introduction
• Overview of Autism Spectrum Disorders
  • Disease Defi nitions and Symptoms
  • Etiology
  • Diagnosis
• Epidemiology
  • Overview
  • Disease Defi nition
  • Methods
  • Prevalence Trends
  • Subpopulations
• Treatment Approaches for Autistic Spectrum Disorder
  • Atypical Antipsychotics
  • Serotonin Reuptake Inhibitors
  • Stimulants
  • Other Drug Treatments
• Emerging Treatments for Autism Spectrum Disorders
  • Forest Laboratories/Merz' s Memantine
  • BioMarin' s Kuvan
  • Seaside Therapeutics' STX-209
  • Curemark' s CM-AT
• Market Outlook
• Appendix A. Bibliography
• Appendix B. Physicians and Researchers Interviewed - Autism

Tables

• 1. Thought Leader Opinion on Autism Spectrum Disorder
• 2. Select Genes Associated with Autism
• 3. Common Screening Tools for Autism
• 4. Key Sources for Epidemiology Estimates - Autism Spectrum Disorder
• 5. Emerging Agents for the Treatment of Autism
• 6. Sales of Drugs to Treat Autism Spectrum Disorder, 2008

Figures

• 7. Number of Total Diagnosed Prevalent Cases of Autism Spectrum Disorder in the United States, 2008-2018